Healthcare -
Biotechnology - NASDAQ - US
$ 6.58
-0.303 %
$ 326 M
Market Cap
-1.31
P/E
RGNX - ACCOUNTS PAYABLE
Accounts Payable RGNX - REGENXBIO Inc.
22.8 M
LAST VALUE
41.46%
2 YEAR CAGR
38.87%
5 YEAR CAGR
54.14%
10 YEAR CAGR